Scientists search for clues in newborn cells to fight rare bleeding disorder
NCT ID NCT05632484
Summary
This study aimed to better understand Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that causes abnormal blood vessel formation and bleeding. Researchers collected umbilical cord blood and tissue from 16 newborns who had a parent with HHT. They grew and analyzed special cells from these samples to see how they differ from healthy cells, hoping to discover new targets for future therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY HAEMORRHAGIC TELANGIECTASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Estaing
Clermont-Ferrand, 63100, France
-
Hôpital Femme-mère-Enfant
Bron, 69677, France
-
Hôpital St Eloi
Montpellier, 34295, France
Conditions
Explore the condition pages connected to this study.